MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation

Published:2021-01-04 Issue:1 Volume:131 Page:
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Fang Yuanzhang^ORCID,Wang Lifei,Wan Changlin,Sun Yifan^ORCID,Van der Jeught Kevin^ORCID,Zhou Zhuolong,Dong Tianhan,So Ka Man,Yu Tao,Li Yujing,Eyvani Haniyeh,Colter Austyn B.,Dong Edward,Cao Sha^ORCID,Wang Jin^ORCID,Schneider Bryan P.,Sandusky George E.,Liu Yunlong^ORCID,Zhang Chi^ORCID,Lu Xiongbin,Zhang Xinna

Funder

National Cancer Institute

American Cancer Society Institutional Research Grant

Vera Bradley Foundation for Breast Cancer Research

Indiana University School of Medicine Strategic Research Initiative

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/140837/files/pdf

Reference66 articles.

1. Cancer immunotherapy using checkpoint blockade

2. Checkpoint inhibitors in triple-negative breast cancer (TNBC): Where to go from here

3. A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging

4. Adoptive cell transfer as personalized immunotherapy for human cancer

5. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATF1 regulates MAL2 expression through inhibition of miR-630 to mediate the EMT process that promotes cervical cancer cell development and metastasis;Journal of Gynecologic Oncology;2025

2. Targeting the MHC-I endosomal-lysosomal trafficking pathway in cancer: From mechanism to immunotherapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Molecular characteristics and oncogenic role of CHD family genes: a pan-cancer analysis based on bioinformatic and biological analysis;Scientific Reports;2024-08-15

4. Nilotinib boosts the efficacy of anti-PDL1 therapy in colorectal cancer by restoring the expression of MHC-I;Journal of Translational Medicine;2024-08-14

5. A bibliometric analysis of drug resistance in immunotherapy for breast cancer: trends, themes, and research focus;Frontiers in Immunology;2024-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3